Related Experiment Video
Updated: Jun 29, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in
Irene Clares-Pedrero1, Almudena Rocha-Mulero1, Miguel Palma-Cobo1
1Tissue and Organ Homeostasis Program, Cell-Cell Communication Unit, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, Spain.
Abstract:
Extracellular vesicles produced by tumor cells (TEVs) influence all stages of cancer development and spread, including tumorigenesis, cancer progression, and metastasis. TEVs can trigger profound phenotypic and functional changes in target cells through three main general mechanisms: (i) docking of TEVs on target cells and triggering of intra-cellular signaling; (ii) fusion of TEVs and target cell membranes with release of TEVs molecular cargo in the cytoplasm of recipient cell; and (iii) uptake of TEVs by recipient cells. Though the overall tumor-promoting effects of TEVs as well as the general mechanisms involved in TEVs interactions with, and uptake by, recipient cells are relatively well established, current knowledge about the molecular determinants that mediate the docking and uptake of tumor-derived EVs by specific target cells is still rather deficient. These molecular determinants dictate the cell and organ tropism of TEVs and ultimately control the specificity of TEVs-promoted metastases. Here, we will review current knowledge on selected specific molecules that mediate the tropism of TEVs towards specific target cells and organs, including the integrins, ICAM-1 Inter-Cellular Adhesion Molecule), ALCAM (Activated Leukocyte Cell Adhesion Molecule), CD44, the metalloproteinases ADAM17 (A Disintegrin And Metalloproteinase member 17) and ADAM10 (A Disintegrin And Metalloproteinase member 10), and the tetraspanin CD9.
Insights
Tumor-derived extracellular vesicles (TEVs) drive cancer progression and metastasis. This review highlights key molecules like integrins and CD44 that mediate TEV targeting of specific cells and organs, crucial for understanding cancer spread.
Area of Science:
- Cancer Biology
- Cellular and Molecular Biology
- Extracellular Vesicles Research
Background:
- Tumor-derived extracellular vesicles (TEVs) are critical mediators of cancer progression, influencing tumorigenesis, growth, and metastasis.
- TEVs interact with target cells via docking, membrane fusion, or uptake, delivering molecular cargo and inducing cellular changes.
- While TEV functions are known, the specific molecular mechanisms governing their tropism to target cells and organs remain incompletely understood.
Purpose of the Study:
- To review the current knowledge on molecular determinants mediating the tropism of TEVs.
- To elucidate how these molecules dictate the specificity of TEV interactions with target cells and organs.
- To highlight the role of these determinants in controlling metastasis specificity.
Main Methods:
- Literature review of studies investigating molecular interactions of TEVs with target cells.
- Analysis of identified molecules involved in TEV docking, fusion, and uptake processes.
- Synthesis of information on cell adhesion molecules, proteases, and tetraspanins implicated in TEV tropism.
Main Results:
- Key molecules mediating TEV tropism include integrins, ICAM-1, ALCAM, CD44, ADAM17, ADAM10, and CD9.
- These molecules facilitate specific binding and uptake of TEVs by recipient cells, influencing their destination.
- Understanding these interactions is vital for deciphering the organ-specific patterns of cancer metastasis.
Conclusions:
- Specific molecular determinants on TEVs and target cells govern their tropism and interaction specificity.
- These interactions are fundamental to the process of metastasis and organ colonization by cancer cells.
- Targeting these molecular mediators may offer novel therapeutic strategies for controlling cancer spread.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Tumor Microenvironment
Intralumenal Vesicles and Multivesicular Bodies

